Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;50:392-395
Published online before print June 25, 2007, doi: 10.1161/HYPERTENSIONAHA.107.092197
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
50/2/392    most recent
HYPERTENSIONAHA.107.092197v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNiece, K. L.
Right arrow Articles by Portman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNiece, K. L.
Right arrow Articles by Portman, R. J.
Related Collections
Right arrow Other hypertension
Right arrow Hypertrophy
Right arrow Clinical Studies

(Hypertension. 2007;50:392.)
© 2007 American Heart Association, Inc.


Original Articles

Left Ventricular Hypertrophy in Hypertensive Adolescents

Analysis of Risk by 2004 National High Blood Pressure Education Program Working Group Staging Criteria

Karen L. McNiece; Monesha Gupta-Malhotra; Joshua Samuels; Cynthia Bell; Kathleen Garcia; Timothy Poffenbarger; Jonathan M. Sorof; Ronald J. Portman

From the Department of Pediatrics, Division of Pediatric Nephrology and Hypertension (K.L.M., J.S., C.B., T.P., R.J.P.), and Department of Pediatrics, Division of Pediatric Cardiology (M.G.-M.), School of Medicine, University of Texas, Houston; Wyle Laboratories (K.G.), Houston, Tex; and AstraZeneca Pharmaceuticals, Wilmington, Del (J.M.S.).

Correspondence to Karen L. McNiece, Division of Pediatric Nephrology and Hypertension, University of Texas-Houston, School of Medicine, 6431 Fannin St, MSB 3.124, Houston, TX 77057. E-mail karen.l.mcniece{at}uth.tmc.edu

The National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents recently recommended staging hypertension (HTN) in children and adolescents based on blood pressure severity. The use of blood pressure staging and its corresponding therapeutic approach was examined in this pooled analysis assessing the risk for end-organ damage, specifically left ventricular hypertrophy among hypertensive adolescents stratified by working group criteria. Newly diagnosed hypertensive adolescents and normotensive control subjects similar in age, race/ethnicity, gender, and body mass index completed casual and 24-hour ambulatory blood pressure measurements, M-mode echocardiography, and fasting serum laboratories. Hypertensive subjects had higher insulin and cholesterol but similar glucose levels as compared with control subjects. Among subjects with stage 1 HTN by casual blood pressure, 34% had white-coat HTN as opposed to 15% of stage 2 hypertensive subjects. Of the subjects with normal casual measurements, 20% had HTN by ambulatory monitoring. Subjects with stage 2 HTN by casual measurement alone (odds ratio: 4.13; 95% CI: 1.04 to 16.48) and after 24-hour ambulatory confirmation (odds ratio: 7.23; 95% CI: 1.28 to 40.68) had increased odds for left ventricular hypertrophy. In addition, the risk for left ventricular hypertrophy was similar for subjects with masked and confirmed stage 1 HTN, whereas subjects with white-coat HTN had a risk comparable to normotensive subjects. Thus, recommendations that adolescents with stage 2 HTN by casual measurements alone receive medication initially along with therapeutic lifestyle counseling are reasonable, though ambulatory blood pressure monitoring remains a valuable tool for evaluating children with stage 2 HTN, because >10% have white-coat HTN.


Key Words: hypertension • left ventricular hypertrophy • echocardiography • ambulatory blood pressure monitoring • white-coat hypertension • masked hypertension • adolescents




This article has been cited by other articles:


Home page
CirculationHome page
S. Javaheri, A. Storfer-Isser, C. L. Rosen, and S. Redline
Sleep Quality and Elevated Blood Pressure in Adolescents
Circulation, September 2, 2008; 118(10): 1034 - 1040.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Urbina, B. Alpert, J. Flynn, L. Hayman, G. A. Harshfield, M. Jacobson, L. Mahoney, B. McCrindle, M. Mietus-Snyder, J. Steinberger, et al.
Ambulatory Blood Pressure Monitoring in Children and Adolescents: Recommendations for Standard Assessment: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young and the Council for High Blood Pressure Research
Hypertension, September 1, 2008; 52(3): 433 - 451.
[Full Text] [PDF]